{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:39:51Z","timestamp":1792521591743,"version":"4.5.0"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review summarizes the spectrum of ocular manifestations in systemic vasculitis, emphasizing recent advances in clinical recognition, multimodal imaging, biomarkers, and targeted treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Ocular involvement may precede systemic manifestations and affect the anterior segment, retina, choroid, optic nerve, or orbit. In giant cell arteritis, vascular ultrasound is a preferred first-line imaging modality, while orbital and retinal imaging may provide complementary information on ischemic injury and treatment response. Ultra-widefield fluorescein angiography improves the detection of peripheral retinal nonperfusion in Takayasu arteritis. In antineutrophil cytoplasmic antibody\u2013associated vasculitis, particularly granulomatosis with polyangiitis, ocular or orbital inflammation may be the initial or isolated manifestation, and rituximab-based therapy has been associated with favorable outcomes in orbital inflammatory disease. In Beh\u00e7et uveitis, ocular-specific diagnostic criteria, imaging biomarkers, and treat-to-target biologic strategies are emerging. However, many of these approaches require validation in larger prospective studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Prompt recognition and multidisciplinary management are essential to prevent irreversible visual loss. New imaging methods and targeted therapies have broadened diagnostic and therapeutic options. Despite these advances, standardized ocular outcome measures and validation of emerging imaging and molecular biomarkers remain important priorities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001191","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:00:13Z","timestamp":1787727613000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The eye in systemic vasculitis"],"prefix":"10.1097","author":[{"given":"Hilal","family":"Eser-Ozturk","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ondokuz Mayis University, Faculty of Medicine Samsun"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilknur","family":"Tugal-Tutkun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine"},{"name":"Uveitis Service, Eye Protection Foundation, Bayrampasa Eye Hospital, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"R1-20261020","first-page":"593","article-title":"Systemic vasculitis: one year in review","volume":"44","author":"Marvisi","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20261020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.survophthal.2025.06.009","article-title":"Advances in diagnosing and treating giant cell arteritis: new hope for arteritic anterior ischemic optic neuropathy","volume":"71","author":"von der Emde","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"R3-20261020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/rheumatology\/keae042","article-title":"Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry","volume":"64","author":"Molina-Collada","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/01658107.2024.2389934","article-title":"Predictors of permanent vision loss in giant cell arteritis","volume":"49","author":"Tucker","year":"2025","journal-title":"Neuroophthalmology"},{"key":"R5-20261020","first-page":"roag013","article-title":"Clinical characteristics of giant cell arteritis with ocular involvement: a single-centre retrospective study","volume":"20","author":"Kawamoto","year":"2026","journal-title":"Mod Rheumatol"},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"e90066","DOI":"10.1002\/acr2.90066","article-title":"Quantification of vascular burden on cranial vessel wall magnetic resonance imaging and ophthalmic complications in giant cell arteritis","volume":"8","author":"Yang","year":"2026","journal-title":"ACR Open Rheumatol"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"keaf456","DOI":"10.1093\/rheumatology\/keaf456","article-title":"Transorbital ultrasonography reveals persistent decrease in retinal artery flow and optic nerve diameter in treated giant cell arteritis","volume":"65","author":"Petzinna","year":"2025","journal-title":"Rheumatology"},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"1498968","DOI":"10.3389\/fopht.2024.1498968","article-title":"Clinical, laboratory, and orbital imaging features of giant cell arteritis in comparison to nonarteritic anterior ischemic optic neuropath: a single center case series","volume":"4","author":"Eldaya","year":"2024","journal-title":"Front Ophthalmol"},{"key":"R9-20261020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bjo-2024-326608","article-title":"Optic nerve sheath enhancement on orbital MRI in giant cell arteritis","volume":"109","author":"Ephrem","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"R10-20261020","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12880-025-01780-4","article-title":"Diffusion weighted imaging-based differentiation of arteritic and nonarteritic anterior ischemic optic neuropathy","volume":"25","author":"Pietrock","year":"2025","journal-title":"BMC Med Imaging"},{"key":"R11-20261020","doi-asserted-by":"crossref","first-page":"1802935","DOI":"10.3389\/fimmu.2026.1802935","article-title":"[(18)F]-FDG-PET\/CT detects subclinical optic nerve inflammation in giant cell arteritis","volume":"17","author":"Gernert","year":"2026","journal-title":"Front Immunol"},{"key":"R12-20261020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/IAE.0000000000004783","article-title":"OCT and OCT-A findings in giant cell arteritis: PAMM as a specific ischemic marker","volume":"46","author":"Chapron","year":"2026","journal-title":"Retina"},{"key":"R13-20261020","doi-asserted-by":"crossref","first-page":"1771903","DOI":"10.3389\/fopht.2026.1771903","article-title":"Peripapillary hyperreflective ovoid mass-like structure in arteritic versus nonarteritic anterior ischemic optic neuropathy","volume":"6","author":"Maartensson","year":"2026","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"R14-20261020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00296-025-05800-y","article-title":"Imaging of ophthalmic manifestations: optical coherence tomography angiography and transorbital ultrasound in giant cell arteritis","volume":"45","author":"Petzinna","year":"2025","journal-title":"Rheumatol Int"},{"key":"R15-20261020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12886-025-03997-x","article-title":"Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis","volume":"25","author":"Terheyden","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"R16-20261020","doi-asserted-by":"crossref","first-page":"e006334","DOI":"10.1136\/rmdopen-2025-006334","article-title":"Optical coherence tomography angiography detects retinal microvascular changes in giant cell arteritis: the potential protective role of aortitis","volume":"11","author":"Petzinna","year":"2025","journal-title":"RMD Open"},{"key":"R17-20261020","doi-asserted-by":"crossref","first-page":"102316","DOI":"10.1016\/j.ajoc.2025.102316","article-title":"Evaluation of blood flow in arteritic anterior ischemic optic neuropathy using laser speckle flowgraphy: a case series","volume":"38","author":"Yamaguchi","year":"2025","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R18-20261020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajo.2025.03.022","article-title":"Population-based performance of inflammatory markers in giant cell arteritis","volume":"275","author":"Castillejo Becerra","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"R19-20261020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-025-03594-9","article-title":"Prevalence, characteristics, and outcomes of patients with low baseline C-reactive protein in giant cell arteritis","volume":"27","author":"Pichon","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"R20-20261020","doi-asserted-by":"crossref","first-page":"e003397","DOI":"10.1136\/rmdopen-2023-003397","article-title":"New blood biomarkers and imaging for disease stratification and monitoring of giant cell arteritis","volume":"10","author":"Tomelleri","year":"2024","journal-title":"RMD Open"},{"key":"R21-20261020","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa2413449","article-title":"A phase 3 trial of upadacitinib for giant-cell arteritis","volume":"392","author":"Blockmans","year":"2025","journal-title":"N Engl J Med"},{"key":"R22-20261020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1186\/s12886-025-04446-5","article-title":"Takayasu retinopathy unveiling underlying Takayasu arteritis: a case report","volume":"25","author":"Rana","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"R23-20261020","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1080\/09273948.2025.2563713","article-title":"Optic disc and retinal structural changes in takayasu arteritis: implications for normotensive glaucoma","volume":"33","author":"Kizilay","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R24-20261020","doi-asserted-by":"crossref","first-page":"102574","DOI":"10.1016\/j.ajoc.2026.102574","article-title":"Detection of early ocular circulatory changes in Takayasu arteritis using laser speckle flowgraphy","volume":"42","author":"Mimura","year":"2026","journal-title":"Am J Ophthalmol Case Rep"},{"key":"R25-20261020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273948.2026.2661047","article-title":"Takayasu retinopathy findings on ultra-wide field fundus fluorescein angiography","volume":"34","author":"Sharma","year":"2026","journal-title":"Ocul Immunol Inflamm"},{"key":"R26-20261020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.4103\/IJO.IJO_1346_23","article-title":"Posterior segment manifestations of Takayasu arteritis: a narrative review","volume":"72","author":"Sharma","year":"2024","journal-title":"Indian J Ophthalmol"},{"key":"R27-20261020","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s10067-024-07034-y","article-title":"Ocular manifestations in ANCA-associated vasculitis: a comprehensive analysis from Chinese medical centers","volume":"43","author":"Liu","year":"2024","journal-title":"Clin Rheumatol"},{"key":"R28-20261020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12886-025-04031-w","article-title":"Bilateral corneoscleritis with retrocorneal plaque as the initial presentation of granulomatosis with polyangiitis","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"R29-20261020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12886-025-04411-2","article-title":"Granulomatosis with polyangiitis presenting as axial proptosis and corneal perforation-a case report","volume":"25","author":"Bhatia","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"R30-20261020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/mrcr\/rxae066","article-title":"Granulomatosis with polyangiitis with lacrimal gland enlargement and pancreatic swelling: A case report and a literature review","volume":"9","author":"Kawajiri","year":"2025","journal-title":"Mod Rheumatol Case Rep"},{"key":"R31-20261020","doi-asserted-by":"crossref","first-page":"e45044","DOI":"10.1097\/MD.0000000000045044","article-title":"Successful treatment of antineutrophil cytoplasmic antibody-associated inflammatory pseudotumour with rituximab: a case report","volume":"104","author":"Gao","year":"2025","journal-title":"Medicine"},{"key":"R32-20261020","doi-asserted-by":"crossref","first-page":"rxag045","DOI":"10.1093\/mrcr\/rxag045","article-title":"Organ-limited ANCA-associated orbital inflammatory disease: a diagnostic challenge","volume":"10","author":"Sebhat","year":"2026","journal-title":"Mod Rheumatol Case Rep"},{"key":"R33-20261020","doi-asserted-by":"crossref","first-page":"1515622","DOI":"10.3389\/fmed.2025.1515622","article-title":"Optic neuropathy as an early manifestation of granulomatosis with polyangiitis: a case report and literature review","volume":"12","author":"Kim","year":"2025","journal-title":"Front Med"},{"key":"R34-20261020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12348-025-00454-0","article-title":"Recurrent strokes as the sole manifestation of antineutrophil cytoplasmic antibody associated vasculitis in a patientwith panuveitis: a case report","volume":"15","author":"Seraj","year":"2025","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R35-20261020","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1080\/09273948.2025.2573734","article-title":"Peripheral ulcerative keratitis as an initial manifestation of granulomatosis with polyangiitis in a pediatric patient: a case report","volume":"33","author":"Cardona-L\u00f3pez","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R36-20261020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12882-026-04828-x","article-title":"Reversible choroidal ischemia as a rare sight-threatening manifestation of microscopic polyangiitis presenting with crescentic glomerulonephritis","volume":"27","author":"Icacan","year":"2026","journal-title":"BMC Nephrol"},{"key":"R37-20261020","doi-asserted-by":"crossref","first-page":"rxaf068","DOI":"10.1093\/mrcr\/rxaf068","article-title":"When vision loss signals vasculitis: central retinal artery occlusion leading to microscopic polyangiitis diagnosis-a case report","volume":"9","author":"Kamada","year":"2025","journal-title":"Mod Rheumatol Case Rep"},{"key":"R38-20261020","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1080\/09273948.2025.2529342","article-title":"A case of orbital inflammation as the initial manifestation of eosinophilic granulomatosis with polyangiitis following dupilumab administration, successfully treated with mepolizumab","volume":"33","author":"Aya","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R39-20261020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/WNO.0000000000002318","article-title":"Eosinophilic granulomatosis with polyangiitis presenting with neuro-ophthalmic manifestations","volume":"45","author":"Noorani","year":"2025","journal-title":"J Neuroophthalmol"},{"key":"R40-20261020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/09273948.2025.2486361","article-title":"Ischemic ocular involvement in eosinophilic granulomatosis with polyangiitis: a case report","volume":"33","author":"Laburthe","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R41-20261020","doi-asserted-by":"crossref","first-page":"rxaf056","DOI":"10.1093\/mrcr\/rxaf056","article-title":"Sudden visual loss and hypereosinophilia: a case of eosinophilic granulomatosis with polyangiitis","volume":"9","author":"Aita","year":"2025","journal-title":"Mod Rheumatol Case Rep"},{"key":"R42-20261020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12348-026-00583-0","article-title":"Unilateral orbital mass as the initial presentation of pediatric antineutrophil cytoplasmic antibody associated vasculitis: eosinophilic granulomatosis with polyangiitis versus granulomatosis with polyangiitis","volume":"16","author":"Bonny","year":"2026","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"R43-20261020","doi-asserted-by":"crossref","first-page":"152900","DOI":"10.1016\/j.semarthrit.2025.152900","article-title":"Management of antineutrophil cytoplasmic antibody vasculitis-associated orbital inflammatory disease: a systematic literature review","volume":"76","author":"Neary","year":"2026","journal-title":"Semin Arthritis Rheum"},{"key":"R44-20261020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40123-025-01258-0","article-title":"The risk of developing ocular involvement among beh\u00e7et's disease patients presenting with mucocutaneous involvement at disease onset: data from the International AIDA Network Beh\u00e7et's Disease Registry","volume":"15","author":"Vitale","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"R45-20261020","first-page":"e90066","article-title":"Development of diagnostic criteria for Behcet's uveitis in a Chinese population","volume":"8","author":"Yang","year":"2026","journal-title":"Br J Ophthalmol"},{"key":"R46-20261020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00296-025-05892-6","article-title":"High prevalence of HLA-B51 and ocular involvement in Behcet's disease: a multicenter cross-sectional study","volume":"45","author":"Nokhatha","year":"2025","journal-title":"Rheumatol Int"},{"key":"R47-20261020","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1007\/s10067-025-07628-0","article-title":"STAT3 rs1053005\u200a(T\/C) contributes to Behcet's disease risk and ocular lesions","volume":"44","author":"Lahmar","year":"2025","journal-title":"Clin Rheumatol"},{"key":"R48-20261020","doi-asserted-by":"crossref","first-page":"11795441251412830","DOI":"10.1177\/11795441251412830","article-title":"Systemic immune-inflammation index as a marker of activity in Behcet's uveitis","volume":"19","author":"Ashour","year":"2026","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"key":"R49-20261020","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1007\/s00417-025-06896-5","article-title":"Inflammatory hematological ratios and subclinical microvascular changes of fundus in Behcet disease","volume":"263","author":"Hong","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R50-20261020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.31138\/mjr.200625.era","article-title":"Pan-immune-inflammation value predicts disease activity and ocular involvement in behcet's disease: a case-control study","volume":"37","author":"Shawky","year":"2026","journal-title":"Mediterr J Rheumatol"},{"key":"R51-20261020","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1080\/09273948.2025.2491568","article-title":"Association of optical coherence tomography angiography biomarkers with fluorescein angiography retinal inflammation scores in Behcet's retinal vasculitis","volume":"33","author":"Ghanbarnia","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R52-20261020","doi-asserted-by":"crossref","first-page":"e0323192","DOI":"10.1371\/journal.pone.0323192","article-title":"OCTA measurements in Behcet's disease across different stages of the disease activity: a systematic review and meta-analysis","volume":"20","author":"Mozafar","year":"2025","journal-title":"PLoS One"},{"key":"R53-20261020","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1080\/09273948.2025.2495073","article-title":"A novel diagnostic and subtype classification model based on RNA N6-methyladenosine regulators for Behcet's uveitis","volume":"33","author":"Gu","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R54-20261020","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1007\/s10753-025-02305-5","article-title":"Proteomic profiles of neutrophils from behcet's uveitis patients and their sex differences","volume":"48","author":"Liu","year":"2025","journal-title":"Inflammation"},{"key":"R55-20261020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12967-025-07520-0","article-title":"Single-cell transcriptomic profiling reveals aberrant CD4+ naive T cell differentiation driving immune activation in Beh\u00e7et's uveitis","volume":"24","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"R56-20261020","doi-asserted-by":"crossref","first-page":"e2411524","DOI":"10.1002\/advs.202411524","article-title":"NETs-CD44-IL-17A feedback loop drives Th17-mediated inflammation in Behcet's uveitis","volume":"12","author":"Wu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"R57-20261020","doi-asserted-by":"crossref","first-page":"e17843","DOI":"10.1002\/advs.202417843","article-title":"Integrated transcriptome and metabolomics analyses show MYC as a potential therapeutic target for Behcet's uveitis","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"R58-20261020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajo.2026.01.006","article-title":"Adalimumab-induced changes in NK cells phenotype, receptors, and functions after clinical remission of Behcet's uveitis","volume":"284","author":"Esen","year":"2026","journal-title":"Am J Ophthalmol"},{"key":"R59-20261020","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ard.2026.02.009","article-title":"EULAR recommendations for the management of Behcet's syndrome: 2025 update","volume":"85","author":"Hatemi","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"R60-20261020","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.apjo.2025.100261","article-title":"International consensuses and guidelines on managing ocular Beh\u00e7et's disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII), and the Academia Retina Internation","volume":"14","author":"Chan","year":"2025","journal-title":"Asia-Pac J Ophthalmol"},{"key":"R61-20261020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41584-026-01381-7","article-title":"Treat-to-target in Behcet syndrome","volume":"22","author":"Bettiol","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"R62-20261020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/art.43382","article-title":"Comparative real-world effectiveness of immunomodulatory therapies for prevention of uveitis relapse in Behcet disease","volume":"78","author":"Zhong","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"R63-20261020","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s00417-025-06938-y","article-title":"Network meta-analysis of immunomodulatory therapies for Behcet's disease-associated uveitis: comparative evaluation of safety and efficacy profiles","volume":"263","author":"Krungkraipetch","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R64-20261020","doi-asserted-by":"crossref","first-page":"keag086","DOI":"10.1093\/rheumatology\/keag086","article-title":"The use of non-TNF targeted biologics in Behcet's disease: real-life data from the International AIDA Network Behcet's Disease Registry","volume":"65","author":"Sevik","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R65-20261020","doi-asserted-by":"crossref","first-page":"153025","DOI":"10.1016\/j.semarthrit.2026.153025","article-title":"Efficacy and safety of JAK inhibitors in Behcet syndrome: systematic literature review","volume":"80","author":"Sulu","year":"2026","journal-title":"Semin Arthritis Rheum"},{"key":"R66-20261020","doi-asserted-by":"crossref","DOI":"10.1007\/s00417-026-07293-2","article-title":"Comparative efficacy and safety of tofacitinib versus adalimumab in patients with Behcet's uveitis: a real-world retrospective study","author":"Shu","year":"2026","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R67-20261020","doi-asserted-by":"crossref","first-page":"1617653","DOI":"10.3389\/fimmu.2026.1617653","article-title":"Visual prognosis of Behcet's uveitis patients in China and its associated factors","volume":"17","author":"Pei","year":"2026","journal-title":"Front Immunol"},{"key":"R68-20261020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/09273948.2025.2467435","article-title":"Long-term outcomes of uveoretinitis in Behcet's disease in the era of biologic treatments: a 10-year follow-up study","volume":"33","author":"Sugawara","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"R69-20261020","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2147\/OPTH.S524282","article-title":"Systemic immunomodulatory therapy in uveitis related to Behcet's disease: a 10-year profile","volume":"19","author":"Almeida","year":"2025","journal-title":"Clin Ophthalmol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:00:16Z","timestamp":1792519216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":69,"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001191","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}